MED7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.852200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.605200E-01
Normal-vs-Stage2
6.312300E-02
Normal-vs-Stage3
1.944360E-01
Normal-vs-Stage4
3.679600E-01
Stage1-vs-Stage2
5.304200E-02
Stage1-vs-Stage3
1.276370E-01
Stage1-vs-Stage4
3.878200E-01
Stage2-vs-Stage3
5.972200E-01
Stage2-vs-Stage4
5.833600E-01
Stage3-vs-Stage4
5.275800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.205600E-02
Normal-vs-AfricanAmerican
4.797800E-02
Normal-vs-Asian
4.704600E-01
Caucasian-vs-AfricanAmerican
2.291400E-01
Caucasian-vs-Asian
2.161600E-01
AfricanAmerican-vs-Asian
1.743200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.388000E-02
Normal-vs-Female
1.454190E-01
Male-vs-Female
3.064400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.860200E-01
Normal-vs-Age(41-60Yrs)
1.539790E-01
Normal-vs-Age(61-80Yrs)
6.151800E-02
Normal-vs-Age(81-100Yrs)
4.664200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.035600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.152000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.191000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.624300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.362800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.784200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.121200E-01
Normal-vs-Daily Drinker
7.867700E-02
Normal-vs-Weekly Drinker
4.145800E-02
Normal-vs-Occasional Drinker
2.576000E-01
Normal-vs-Social Drinker
1.152200E-01
Non Drinker-vs-Daily Drinker
8.021000E-01
Non Drinker-vs-Weekly Drinker
1.774800E-01
Non Drinker-vs-Occasional Drinker
6.584000E-01
Non Drinker-vs-Social Drinker
8.910400E-01
Daily Drinker-vs-Weekly Drinker
1.760360E-01
Daily Drinker-vs-Occasional Drinker
4.534600E-01
Daily Drinker-vs-Social Drinker
9.258800E-01
Weekly Drinker-vs-Occasional Drinker
8.147600E-02
Weekly Drinker-vs-Social Drinker
2.024200E-01
Occasional Drinker-vs-Social Drinker
5.629200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.144500E-02
Normal-vs-Grade 2
7.588000E-04
Normal-vs-Grade 3
2.123600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.703420E-01
Grade 1-vs-Grade 3
2.551000E-01
Grade 1-vs-Grade 4
6.144500E-02
Grade 2-vs-Grade 3
7.950400E-01
Grade 2-vs-Grade 4
7.588000E-04
Grade 3-vs-Grade 4
2.123600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.796500E-03
Normal-vs-NonDiabetic
1.284220E-01
Diabetic-vs-NonDiabetic
3.312400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.122200E-01
Normal-vs-NoPancreatitis
6.306300E-02
Pancreatitis-vs-NoPancreatitis
1.540150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.344000E-01
Normal-vs-N1
5.828200E-02
N0-vs-N1
1.565570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.417190E-01
Normal-vs-TP53-NonMutant
1.700970E-01
TP53-Mutant-vs-TP53-NonMutant
4.087600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
